About Lactobacillus salivarius
Renamed from Lactobacillus salivarius to Ligilactobacillus salivarius (2020). A few small RCTs exist (e.g. atopic dermatitis, oral/periodontal health with specific strains) but the clinical evidence base is thin and inconsistent. Graded low: mostly a blend/presence-only component.
What Lactobacillus salivarius supports
- Limited early evidence for gut and oral microbiome support
How much Lactobacillus salivarius to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
1–10
billion_cfu
No established therapeutic dose; small RCTs use ~1-10 billion CFU/day. Usually presence-only in blends; nominal range.
Clinical evidence
Limited clinical evidence. Low: only small, inconsistent strain-specific trials.
Examine.com